Variable | Severe acute pancreatitis (n = 91) | Mild acute pancreatitis (n = 91) | pU/pM | aOR, 95 CI in M |
---|---|---|---|---|
Age (yo), μ ± σ | 64.8 ± 16.3 | 67.9 ± 13.7 | 0.239/− | – |
Male gender, n(%) | 53(58.2%) | 47(51.6%) | 0.228/− | – |
Alcoholism, n(%) | 26(28.6%) | 14(15.4%) | 0.032/− | – |
Smoking, n(%) | 0(0.0%) | 5(5.5%) | 0.023/− | – |
Hospital stay, median(IQR) | 1.3(2–83) | 8.0(2–25) | 0.001/− | – |
Comorbiditiesa, n(%) | 75(82.4%) | 83(91.2%) | 0.08/− | – |
Hypothyroidism | 2(2.2%) | 9(9.9%) | 0.029/− | – |
Cerebral vascular accident | 9(9.9%) | 0(0.0%) | 0.002/− | – |
Chronic renal disease | 10(11.0%) | 3(3.3%) | 0.004/− | – |
Laboratory and gasometrical parameters | ||||
WBC count (cells/mm3), μ ± σ | 15,630.0 ± 9030.0 | 31,165.0 ± 1631.7 | 0.001/− | – |
AST (IU/L), μ ± σ | 193.5 ± 164.1 | 778.9 ± 354.6 | 0.003/− | – |
ALT (IU/L), μ ± σ | 249.7 ± 180.3 | 445.5 ± 252.8 | 0.129/− | – |
Total bilirubin (mg/dL), μ ± σ | 2.7 ± 2.6 | 2.2 ± 1.9 | 0.363/− | – |
Platelet count (cells/mm3), μ ± σ | 212.2 ± 87.1 | 208.8 ± 72.8 | 0.975/− | – |
BUN (mg/dL), μ ± σ | 26.6 ± 17.1 | 19.4 ± 8.8 | 0.009/< 0.001 | 1.002, [1.001;1.007] |
Creatinine (mg/dL), μ ± σ | 1.5 ± 1.3 | 0.9 ± 0.3 | < 0.001/− | – |
INR, μ ± σ | 3.0 ± 1.6 | 1.4 ± 0.2 | < 0.001/− | – |
Albumin (g/dL), μ ± σ | 3.6 ± 0.6 | 4.0 ± 0.7 | < 0.001/− | – |
LDH (IU/L), μ ± σ | 503.0 ± 403.7 | 406.8 ± 305.4 | < 0.001/− | – |
Serum glucose (mg/dL), μ ± σ | 168.0 ± 72.6 | 130.9 ± 35.5 | < 0.001/< 0.001 | 1.002, [1.001;1.317] |
Hemoglobin (mg/dL), μ ± σ | 13.8 ± 2.6 | 13.5 ± 1.4 | 0.406/− | – |
Hematocrit (%), μ ± σ | 41.5 ± 7.0 | 40.2 ± 4.3 | 0.285/− | – |
Serum amylase (IU/L), μ ± σ | 1315.2 ± 1163.3 | 2049.2 ± 1715.0 | 0.398/− | – |
CRP0h (mg/dL), μ ± σ | 10.9 ± 9.2 | 5.0 ± 3.3 | < 0.001/− | – |
CRP24h (mg/dL), μ ± σ | 21.1 ± 11.6 | 11.3 ± 5.8 | < 0.001/− | – |
Lactate (mg/dL), μ ± σ | 2.8 ± 1.7 | 1.5 ± 1.0 | < 0.001/− | – |
D-dimers (μg/mL), μ ± σ | 6.6 ± 6.5 | 1.5 ± 0.3 | 0.192/− | – |
Total serum calcium (mg/dL), μ ± σ | 8.2 ± 1.2 | 9.6 ± 0.4 | < 0.001/− | – |
RDW0h (%), μ ± σ | 14.6 ± 1.3 | 12.7 ± 0.5 | < 0.001/< 0.001 | 1.129, [1.065;1.192] |
RDW24h (%), μ ± σ | 14.3 ± 1.9 | 12.8 ± 0.5 | < 0.001/0.005 | 1.015, [1.003;1.055] |
RDW0h-to-total serum calcium ratio, μ ± σ | 1.8 ± 0.4 | 1.3 ± 0.1 | < 0.001/< 0.001 | 1.556, [1.356;1.756] |
RDW0h-to-platelets ratio, μ ± σ | 0.08 ± 0.03 | 0.07 ± 0.02 | 0.03/− | – |
Prognostic scores | ||||
Ranson score, μ ± σ | 2.6 ± 1.2 | 1.5 ± 0.9 | < 0.001/< 0.001 | 1.043, [1.001;1.088] |
BISAP score, μ ± σ | 1.7 ± 0.9 | 1.0 ± 0.7 | < 0.001/< 0.001 | 1.028, [1.016;1.092] |
Modified Marshall score, μ ± σ | 0.8 ± 0.7 | 0.0 ± 0.0 | < 0.001/< 0.001 | 1.184, [1.112;1.256] |